Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase III Study of Valproic Acid plus All-trans Retinoic Acid with Standard Induction and Consolidation Therapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia
2004-004320-13Phase 3Completed
- Sponsor
- University Hospital Ulm
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of valproic acid in acute myeloid leukemia (AML) (2 arms), sponsored by University Hospital Ulm. Primary endpoint: event-free survival. Started Jul 2005; status: completed.
02
Drugs
valproic acid
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2004-004320-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004320-13.